Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981;6(3):205-10.
doi: 10.1007/BF00256972.

Methodologic problems in clonogenic assays of spontaneous human tumors

Methodologic problems in clonogenic assays of spontaneous human tumors

F R MacKintosh et al. Cancer Chemother Pharmacol. 1981.

Abstract

Colony formation in soft agar was used to investigate growth properties and drug sensitivity in 102 tumor specimens from 91 patients. Sufficient colony growth for sensitivity testing with various drugs was obtained in 36 of 67 specimens (54%) with adequate cell yield and pathologically documented malignancy. Room temperature (20-24 degrees C) is superior to both 4 degrees C and 37 degrees C for 12-36 h storage and transport of malignant effusions. By contrast, fine mincing in sterile saline or balanced salt solution, and refrigerated storage (4 degrees C) appear optimal in experiments with three solid tumors. The use of buffered NH4Cl to lyse red blood cells markedly reduced plating efficiencies, and also reduced the percentage of tumors in which drug sensitivities could be tested from 64% to 38%. Several combinations of potential growth factors and culture media have been tested. Insulin enhanced plating efficiency (PE) in all six adenocarcinomas tested. Drug sensitivity of tumors was not affected by varying plating efficiency up to five-fold in two tumors. In eleven cases tumor cells were exposed to combinations of two or more drugs, and results assessed for evidence of drug interactions. In almost all cases, these two-drug combinations produced additive cell killing than either antagonistic or greater-than-additive effects.U

PubMed Disclaimer

References

    1. Biochim Biophys Acta. 1970 Dec 29;222(3):565-82 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):85-91 - PubMed
    1. Cancer Res. 1979 Mar;39(3):1133-6 - PubMed
    1. Cancer Chemother Pharmacol. 1981;6(3):265-71 - PubMed
    1. Cancer Res. 1981 Jan;41(1):310-5 - PubMed

Publication types